Global Nucleic Acid-based Therapeutics Market Research Report 2026(Status and Outlook)
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Nucleic Acid-based Therapeutics market size was estimated at USD 580.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid-based Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid-based Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid-based Therapeutics market.
Global Nucleic Acid-based Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Market Segmentation (by Type)
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Market Segmentation (by Application)
Hospitals
Academic & Research Institutes
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid-based Therapeutics Market
Overview of the regional outlook of the Nucleic Acid-based Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid-based Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid-based Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nucleic Acid-based Therapeutics market size was estimated at USD 580.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid-based Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid-based Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid-based Therapeutics market.
Global Nucleic Acid-based Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Market Segmentation (by Type)
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Market Segmentation (by Application)
Hospitals
Academic & Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid-based Therapeutics Market
Overview of the regional outlook of the Nucleic Acid-based Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid-based Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid-based Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nucleic Acid-based Therapeutics
1.2 Key Market Segments
1.2.1 Nucleic Acid-based Therapeutics Segment by Type
1.2.2 Nucleic Acid-based Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID-BASED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid-based Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid-based Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID-BASED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid-based Therapeutics Product Life Cycle
3.3 Global Nucleic Acid-based Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid-based Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid-based Therapeutics Market Competitive Situation and Trends
3.8.1 Nucleic Acid-based Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid-based Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid-based Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID-BASED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid-based Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid-based Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID-BASED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid-based Therapeutics Market Size by Type (2020-2025)
6.4 Global Nucleic Acid-based Therapeutics Price by Type (2020-2025)
7 NUCLEIC ACID-BASED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid-based Therapeutics Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid-based Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID-BASED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Region
8.2 Global Nucleic Acid-based Therapeutics Market Size by Region
8.2.1 Global Nucleic Acid-based Therapeutics Market Size by Region
8.2.2 Global Nucleic Acid-based Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid-based Therapeutics Sales by Country
8.3.2 North America Nucleic Acid-based Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid-based Therapeutics Sales by Country
8.4.2 Europe Nucleic Acid-based Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid-based Therapeutics Sales by Region
8.5.2 Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid-based Therapeutics Sales by Country
8.6.2 South America Nucleic Acid-based Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid-based Therapeutics Sales by Region
8.7.2 Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID-BASED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid-based Therapeutics by Region(2020-2025)
9.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid-based Therapeutics Production
9.4.1 North America Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid-based Therapeutics Production
9.5.1 Europe Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid-based Therapeutics Production (2020-2025)
9.6.1 Japan Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid-based Therapeutics Production (2020-2025)
9.7.1 China Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Wave Life Sciences
10.1.1 Wave Life Sciences Basic Information
10.1.2 Wave Life Sciences Nucleic Acid-based Therapeutics Product Overview
10.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Product Market Performance
10.1.4 Wave Life Sciences Business Overview
10.1.5 Wave Life Sciences SWOT Analysis
10.1.6 Wave Life Sciences Recent Developments
10.2 Imugene
10.2.1 Imugene Basic Information
10.2.2 Imugene Nucleic Acid-based Therapeutics Product Overview
10.2.3 Imugene Nucleic Acid-based Therapeutics Product Market Performance
10.2.4 Imugene Business Overview
10.2.5 Imugene SWOT Analysis
10.2.6 Imugene Recent Developments
10.3 Caperna
10.3.1 Caperna Basic Information
10.3.2 Caperna Nucleic Acid-based Therapeutics Product Overview
10.3.3 Caperna Nucleic Acid-based Therapeutics Product Market Performance
10.3.4 Caperna Business Overview
10.3.5 Caperna SWOT Analysis
10.3.6 Caperna Recent Developments
10.4 Phylogica
10.4.1 Phylogica Basic Information
10.4.2 Phylogica Nucleic Acid-based Therapeutics Product Overview
10.4.3 Phylogica Nucleic Acid-based Therapeutics Product Market Performance
10.4.4 Phylogica Business Overview
10.4.5 Phylogica Recent Developments
10.5 Protagonist Therapeutics
10.5.1 Protagonist Therapeutics Basic Information
10.5.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Overview
10.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
10.5.4 Protagonist Therapeutics Business Overview
10.5.5 Protagonist Therapeutics Recent Developments
10.6 Benitec Biopharma
10.6.1 Benitec Biopharma Basic Information
10.6.2 Benitec Biopharma Nucleic Acid-based Therapeutics Product Overview
10.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Product Market Performance
10.6.4 Benitec Biopharma Business Overview
10.6.5 Benitec Biopharma Recent Developments
10.7 EGEN
10.7.1 EGEN Basic Information
10.7.2 EGEN Nucleic Acid-based Therapeutics Product Overview
10.7.3 EGEN Nucleic Acid-based Therapeutics Product Market Performance
10.7.4 EGEN Business Overview
10.7.5 EGEN Recent Developments
10.8 BioMedica
10.8.1 BioMedica Basic Information
10.8.2 BioMedica Nucleic Acid-based Therapeutics Product Overview
10.8.3 BioMedica Nucleic Acid-based Therapeutics Product Market Performance
10.8.4 BioMedica Business Overview
10.8.5 BioMedica Recent Developments
10.9 Transgene
10.9.1 Transgene Basic Information
10.9.2 Transgene Nucleic Acid-based Therapeutics Product Overview
10.9.3 Transgene Nucleic Acid-based Therapeutics Product Market Performance
10.9.4 Transgene Business Overview
10.9.5 Transgene Recent Developments
10.10 Copernicus Therapeutics
10.10.1 Copernicus Therapeutics Basic Information
10.10.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Overview
10.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
10.10.4 Copernicus Therapeutics Business Overview
10.10.5 Copernicus Therapeutics Recent Developments
11 NUCLEIC ACID-BASED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Nucleic Acid-based Therapeutics Market Size Forecast
11.2 Global Nucleic Acid-based Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid-based Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid-based Therapeutics Market Size Forecast by Region
11.2.4 South America Nucleic Acid-based Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid-based Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid-based Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid-based Therapeutics by Type (2026-2035)
12.1.2 Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid-based Therapeutics by Type (2026-2035)
12.2 Global Nucleic Acid-based Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid-based Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid-based Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nucleic Acid-based Therapeutics
1.2 Key Market Segments
1.2.1 Nucleic Acid-based Therapeutics Segment by Type
1.2.2 Nucleic Acid-based Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID-BASED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid-based Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid-based Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID-BASED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid-based Therapeutics Product Life Cycle
3.3 Global Nucleic Acid-based Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid-based Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid-based Therapeutics Market Competitive Situation and Trends
3.8.1 Nucleic Acid-based Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid-based Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid-based Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID-BASED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid-based Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid-based Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID-BASED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid-based Therapeutics Market Size by Type (2020-2025)
6.4 Global Nucleic Acid-based Therapeutics Price by Type (2020-2025)
7 NUCLEIC ACID-BASED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid-based Therapeutics Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid-based Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID-BASED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Region
8.2 Global Nucleic Acid-based Therapeutics Market Size by Region
8.2.1 Global Nucleic Acid-based Therapeutics Market Size by Region
8.2.2 Global Nucleic Acid-based Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid-based Therapeutics Sales by Country
8.3.2 North America Nucleic Acid-based Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid-based Therapeutics Sales by Country
8.4.2 Europe Nucleic Acid-based Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid-based Therapeutics Sales by Region
8.5.2 Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid-based Therapeutics Sales by Country
8.6.2 South America Nucleic Acid-based Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid-based Therapeutics Sales by Region
8.7.2 Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID-BASED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid-based Therapeutics by Region(2020-2025)
9.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid-based Therapeutics Production
9.4.1 North America Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid-based Therapeutics Production
9.5.1 Europe Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid-based Therapeutics Production (2020-2025)
9.6.1 Japan Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid-based Therapeutics Production (2020-2025)
9.7.1 China Nucleic Acid-based Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Wave Life Sciences
10.1.1 Wave Life Sciences Basic Information
10.1.2 Wave Life Sciences Nucleic Acid-based Therapeutics Product Overview
10.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Product Market Performance
10.1.4 Wave Life Sciences Business Overview
10.1.5 Wave Life Sciences SWOT Analysis
10.1.6 Wave Life Sciences Recent Developments
10.2 Imugene
10.2.1 Imugene Basic Information
10.2.2 Imugene Nucleic Acid-based Therapeutics Product Overview
10.2.3 Imugene Nucleic Acid-based Therapeutics Product Market Performance
10.2.4 Imugene Business Overview
10.2.5 Imugene SWOT Analysis
10.2.6 Imugene Recent Developments
10.3 Caperna
10.3.1 Caperna Basic Information
10.3.2 Caperna Nucleic Acid-based Therapeutics Product Overview
10.3.3 Caperna Nucleic Acid-based Therapeutics Product Market Performance
10.3.4 Caperna Business Overview
10.3.5 Caperna SWOT Analysis
10.3.6 Caperna Recent Developments
10.4 Phylogica
10.4.1 Phylogica Basic Information
10.4.2 Phylogica Nucleic Acid-based Therapeutics Product Overview
10.4.3 Phylogica Nucleic Acid-based Therapeutics Product Market Performance
10.4.4 Phylogica Business Overview
10.4.5 Phylogica Recent Developments
10.5 Protagonist Therapeutics
10.5.1 Protagonist Therapeutics Basic Information
10.5.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Overview
10.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
10.5.4 Protagonist Therapeutics Business Overview
10.5.5 Protagonist Therapeutics Recent Developments
10.6 Benitec Biopharma
10.6.1 Benitec Biopharma Basic Information
10.6.2 Benitec Biopharma Nucleic Acid-based Therapeutics Product Overview
10.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Product Market Performance
10.6.4 Benitec Biopharma Business Overview
10.6.5 Benitec Biopharma Recent Developments
10.7 EGEN
10.7.1 EGEN Basic Information
10.7.2 EGEN Nucleic Acid-based Therapeutics Product Overview
10.7.3 EGEN Nucleic Acid-based Therapeutics Product Market Performance
10.7.4 EGEN Business Overview
10.7.5 EGEN Recent Developments
10.8 BioMedica
10.8.1 BioMedica Basic Information
10.8.2 BioMedica Nucleic Acid-based Therapeutics Product Overview
10.8.3 BioMedica Nucleic Acid-based Therapeutics Product Market Performance
10.8.4 BioMedica Business Overview
10.8.5 BioMedica Recent Developments
10.9 Transgene
10.9.1 Transgene Basic Information
10.9.2 Transgene Nucleic Acid-based Therapeutics Product Overview
10.9.3 Transgene Nucleic Acid-based Therapeutics Product Market Performance
10.9.4 Transgene Business Overview
10.9.5 Transgene Recent Developments
10.10 Copernicus Therapeutics
10.10.1 Copernicus Therapeutics Basic Information
10.10.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Overview
10.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
10.10.4 Copernicus Therapeutics Business Overview
10.10.5 Copernicus Therapeutics Recent Developments
11 NUCLEIC ACID-BASED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Nucleic Acid-based Therapeutics Market Size Forecast
11.2 Global Nucleic Acid-based Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid-based Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid-based Therapeutics Market Size Forecast by Region
11.2.4 South America Nucleic Acid-based Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid-based Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid-based Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid-based Therapeutics by Type (2026-2035)
12.1.2 Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid-based Therapeutics by Type (2026-2035)
12.2 Global Nucleic Acid-based Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid-based Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid-based Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid-based Therapeutics Market Size by Type (M USD)
Table 4. Global Nucleic Acid-based Therapeutics Market Size by Application
Table 5. Nucleic Acid-based Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid-based Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid-based Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid-based Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid-based Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2025)
Table 11. Global Market Nucleic Acid-based Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid-based Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid-based Therapeutics Sales by Type (K Units)
Table 27. Global Nucleic Acid-based Therapeutics Market Size by Type (M USD)
Table 28. Global Nucleic Acid-based Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid-based Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid-based Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid-based Therapeutics Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid-based Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid-based Therapeutics Sales (K Units) by Application
Table 34. Global Nucleic Acid-based Therapeutics Market Size by Application
Table 35. Global Nucleic Acid-based Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid-based Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid-based Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid-based Therapeutics Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid-based Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid-based Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid-based Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid-based Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Wave Life Sciences Basic Information
Table 63. Wave Life Sciences Nucleic Acid-based Therapeutics Product Overview
Table 64. Wave Life Sciences Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Wave Life Sciences Business Overview
Table 66. Wave Life Sciences SWOT Analysis
Table 67. Wave Life Sciences Recent Developments
Table 68. Imugene Basic Information
Table 69. Imugene Nucleic Acid-based Therapeutics Product Overview
Table 70. Imugene Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Imugene Business Overview
Table 72. Imugene SWOT Analysis
Table 73. Imugene Recent Developments
Table 74. Caperna Basic Information
Table 75. Caperna Nucleic Acid-based Therapeutics Product Overview
Table 76. Caperna Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Caperna Business Overview
Table 78. Caperna SWOT Analysis
Table 79. Caperna Recent Developments
Table 80. Phylogica Basic Information
Table 81. Phylogica Nucleic Acid-based Therapeutics Product Overview
Table 82. Phylogica Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Phylogica Business Overview
Table 84. Phylogica Recent Developments
Table 85. Protagonist Therapeutics Basic Information
Table 86. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Overview
Table 87. Protagonist Therapeutics Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Protagonist Therapeutics Business Overview
Table 89. Protagonist Therapeutics Recent Developments
Table 90. Benitec Biopharma Basic Information
Table 91. Benitec Biopharma Nucleic Acid-based Therapeutics Product Overview
Table 92. Benitec Biopharma Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Benitec Biopharma Business Overview
Table 94. Benitec Biopharma Recent Developments
Table 95. EGEN Basic Information
Table 96. EGEN Nucleic Acid-based Therapeutics Product Overview
Table 97. EGEN Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. EGEN Business Overview
Table 99. EGEN Recent Developments
Table 100. BioMedica Basic Information
Table 101. BioMedica Nucleic Acid-based Therapeutics Product Overview
Table 102. BioMedica Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BioMedica Business Overview
Table 104. BioMedica Recent Developments
Table 105. Transgene Basic Information
Table 106. Transgene Nucleic Acid-based Therapeutics Product Overview
Table 107. Transgene Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Transgene Business Overview
Table 109. Transgene Recent Developments
Table 110. Copernicus Therapeutics Basic Information
Table 111. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Overview
Table 112. Copernicus Therapeutics Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Copernicus Therapeutics Business Overview
Table 114. Copernicus Therapeutics Recent Developments
Table 115. Global Nucleic Acid-based Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Nucleic Acid-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Nucleic Acid-based Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Nucleic Acid-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Nucleic Acid-based Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Nucleic Acid-based Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Nucleic Acid-based Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Nucleic Acid-based Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid-based Therapeutics Market Size by Type (M USD)
Table 4. Global Nucleic Acid-based Therapeutics Market Size by Application
Table 5. Nucleic Acid-based Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid-based Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid-based Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid-based Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid-based Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2025)
Table 11. Global Market Nucleic Acid-based Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid-based Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid-based Therapeutics Sales by Type (K Units)
Table 27. Global Nucleic Acid-based Therapeutics Market Size by Type (M USD)
Table 28. Global Nucleic Acid-based Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid-based Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid-based Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid-based Therapeutics Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid-based Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid-based Therapeutics Sales (K Units) by Application
Table 34. Global Nucleic Acid-based Therapeutics Market Size by Application
Table 35. Global Nucleic Acid-based Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid-based Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid-based Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid-based Therapeutics Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid-based Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid-based Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid-based Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid-based Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid-based Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid-based Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid-based Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Wave Life Sciences Basic Information
Table 63. Wave Life Sciences Nucleic Acid-based Therapeutics Product Overview
Table 64. Wave Life Sciences Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Wave Life Sciences Business Overview
Table 66. Wave Life Sciences SWOT Analysis
Table 67. Wave Life Sciences Recent Developments
Table 68. Imugene Basic Information
Table 69. Imugene Nucleic Acid-based Therapeutics Product Overview
Table 70. Imugene Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Imugene Business Overview
Table 72. Imugene SWOT Analysis
Table 73. Imugene Recent Developments
Table 74. Caperna Basic Information
Table 75. Caperna Nucleic Acid-based Therapeutics Product Overview
Table 76. Caperna Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Caperna Business Overview
Table 78. Caperna SWOT Analysis
Table 79. Caperna Recent Developments
Table 80. Phylogica Basic Information
Table 81. Phylogica Nucleic Acid-based Therapeutics Product Overview
Table 82. Phylogica Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Phylogica Business Overview
Table 84. Phylogica Recent Developments
Table 85. Protagonist Therapeutics Basic Information
Table 86. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Overview
Table 87. Protagonist Therapeutics Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Protagonist Therapeutics Business Overview
Table 89. Protagonist Therapeutics Recent Developments
Table 90. Benitec Biopharma Basic Information
Table 91. Benitec Biopharma Nucleic Acid-based Therapeutics Product Overview
Table 92. Benitec Biopharma Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Benitec Biopharma Business Overview
Table 94. Benitec Biopharma Recent Developments
Table 95. EGEN Basic Information
Table 96. EGEN Nucleic Acid-based Therapeutics Product Overview
Table 97. EGEN Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. EGEN Business Overview
Table 99. EGEN Recent Developments
Table 100. BioMedica Basic Information
Table 101. BioMedica Nucleic Acid-based Therapeutics Product Overview
Table 102. BioMedica Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BioMedica Business Overview
Table 104. BioMedica Recent Developments
Table 105. Transgene Basic Information
Table 106. Transgene Nucleic Acid-based Therapeutics Product Overview
Table 107. Transgene Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Transgene Business Overview
Table 109. Transgene Recent Developments
Table 110. Copernicus Therapeutics Basic Information
Table 111. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Overview
Table 112. Copernicus Therapeutics Nucleic Acid-based Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Copernicus Therapeutics Business Overview
Table 114. Copernicus Therapeutics Recent Developments
Table 115. Global Nucleic Acid-based Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Nucleic Acid-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Nucleic Acid-based Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Nucleic Acid-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Nucleic Acid-based Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Nucleic Acid-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Nucleic Acid-based Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Nucleic Acid-based Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Nucleic Acid-based Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Nucleic Acid-based Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nucleic Acid-based Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid-based Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid-based Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid-based Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid-based Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid-based Therapeutics Product Life Cycle
Figure 13. Nucleic Acid-based Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid-based Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid-based Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid-based Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid-based Therapeutics
Figure 19. Global Nucleic Acid-based Therapeutics Market PEST Analysis
Figure 20. Global Nucleic Acid-based Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid-based Therapeutics Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid-based Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid-based Therapeutics by Type in 2025
Figure 29. Market Share of Nucleic Acid-based Therapeutics by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid-based Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid-based Therapeutics Market Share by Application
Figure 33. Global Nucleic Acid-based Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid-based Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid-based Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid-based Therapeutics Market Share by Application in 2025
Figure 37. Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid-based Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid-based Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid-based Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid-based Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid-based Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 55. Germany Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid-based Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region in 2024
Figure 68. China Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid-based Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid-based Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid-based Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid-based Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid-based Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid-based Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid-based Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid-based Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid-based Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid-based Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nucleic Acid-based Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid-based Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid-based Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid-based Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid-based Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid-based Therapeutics Product Life Cycle
Figure 13. Nucleic Acid-based Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid-based Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid-based Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid-based Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid-based Therapeutics
Figure 19. Global Nucleic Acid-based Therapeutics Market PEST Analysis
Figure 20. Global Nucleic Acid-based Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid-based Therapeutics Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid-based Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid-based Therapeutics by Type in 2025
Figure 29. Market Share of Nucleic Acid-based Therapeutics by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid-based Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid-based Therapeutics Market Share by Application
Figure 33. Global Nucleic Acid-based Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid-based Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid-based Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid-based Therapeutics Market Share by Application in 2025
Figure 37. Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid-based Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid-based Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid-based Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid-based Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid-based Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 55. Germany Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid-based Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid-based Therapeutics Market Size by Region in 2024
Figure 68. China Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid-based Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid-based Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid-based Therapeutics Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid-based Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid-based Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid-based Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid-based Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid-based Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid-based Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid-based Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid-based Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid-based Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid-based Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid-based Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid-based Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid-based Therapeutics Market Share Forecast by Application (2026-2035)
